The clinical study was a blinded, randomised trial showing plasma concentrations were achieved quickly with a product half-life of about four hours.
The company provides a software as a service (SaaS) platform for social media marketing.
The global specialty beverages company is betting big on cannabis-infused drinks as it gets...
The oncology-focused biotech is a mid-clinical-stage therapeutics company.
Cellmid Limited (ASX:CDY) chief executive officer and managing director Maria Halasz updates Proactive Investors on the company’s key components for its FY2020 growth strategy, which includes an exciting new global product to assist ageing hair. Cellmid is a listed company with health...
Pharma & Biotech
Botanix Pharmaceuticals raises $40mln to push its CBD-based skin...
Pharma & Biotech
Orthocell publishes positive pre-clinical trial study for CelGro...
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
